Redeye retains its Base Case and forecasts following a solid Q2 report from Lagercrantz. Organic growth remains strong, and the company has handled component shortages, rising raw material and freight costs well.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Lagercrantz – Resilient